WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • December 16th, 2019 • Genius Brands International, Inc. • Services-motion picture & video tape production
Contract Type FiledDecember 16th, 2019 Company IndustryThis Warrant Exercise Agreement (this “Agreement”), dated as of December 16, 2019, is by and between Genius Brands International, Inc., a Nevada corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, no par value (the “Common Stock”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • December 16th, 2019 • Genius Brands International, Inc. • Services-motion picture & video tape production
Contract Type FiledDecember 16th, 2019 Company IndustryThis Warrant Exercise Agreement (this “Agreement”), dated as of December 16, 2019, is by and between Genius Brands International, Inc., a Nevada corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, no par value (the “Common Stock”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • December 16th, 2019 • Genius Brands International, Inc. • Services-motion picture & video tape production
Contract Type FiledDecember 16th, 2019 Company IndustryThis Warrant Exercise Agreement (this “Agreement”), dated as of December 16, 2019, is by and between Genius Brands International, Inc., a Nevada corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, no par value (the “Common Stock”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • November 13th, 2017 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 13th, 2017 Company Industry JurisdictionThis Warrant Exercise Agreement (this “Agreement”), dated as of November __, 2017, is by and between OncoSec Medical Incorporated, a Nevada corporation (the “Company”), and the undersigned holders (collectively, the “Holder”) of warrants to purchase shares of the Company’s common stock, no par value (the “Common Stock”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • October 13th, 2017 • Akers Biosciences, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledOctober 13th, 2017 Company IndustryThis Warrant Exercise Agreement (this “Agreement”), dated as of October 12, 2017, is by and between Akers Biosciences, Inc., a New Jersey corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, no par value (the “Common Stock”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • October 12th, 2017 • Interpace Diagnostics Group, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledOctober 12th, 2017 Company IndustryThis Warrant Exercise Agreement (this “Agreement”), dated as of October 12, 2017, is by and between Interpace Diagnostics Group, Inc. a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • July 17th, 2017 • PARETEUM Corp • Services-computer integrated systems design • New York
Contract Type FiledJuly 17th, 2017 Company Industry JurisdictionThis Warrant Exercise Agreement (this “Agreement”), dated as of July 17, 2017, is by and between Pareteum Corporation, a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.00001 per share (the “Common Stock”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • June 19th, 2017 • 22nd Century Group, Inc. • Cigarettes
Contract Type FiledJune 19th, 2017 Company IndustryThis Warrant Exercise Agreement (this “Agreement”), dated as of June 19, 2017, is by and between 22nd Century Group, Inc. a Nevada corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).